Results
- Patients completed pre-screen
- 250
- Patients completed screening at an active site
- 52
- Patients randomized in 9 months
- 24
Situation
A biopharmaceutical company enrolling a phase 2 clinical trial in a very serious neurodegenerative disease wanted help to accelerate clinical trial enrollment.
Approach
- Designed and implemented a compliant patient lead generation program targeting recently diagnosed patients
- Directed patients to a clinical trial website with a digital prescreener
- Activated the Adnexi Portal for 50 sites across the United States and Canada
More case studies
All case studies-
77
digital opinion leaders profiled and tracked for a digital
therapeutic launchDigital therapeutic
160 clinicians surveyed on credibility10+ leaders engaged in the launch
-
40
digital opinion leaders posting about osteoporosis
identified for a planned brand launchOsteoporosis
Filtered by geography, language, recency and channelTracked through their social feeds